
Cardiosense
Geography: Chicago
Indication: Congestive heart failure
Leadership: Amit Gupta
Cardiosense is developing non-invasive sensors and AI to power the next generation of cardiac monitoring. Its lead product, CardioTag, is a small, wearable device placed on the sternum that uses machine learning to predict decompensation in heart failure patients. Designed as a non-invasive alternative to implantable monitors, CardioTag aims to enable earlier intervention and improved patient outcomes.
Visit Site
© 2026 Portal Innovations LLC
Capital. Space. Expertise.
